Ferreyra Gabriela P, Baussano Iacopo, Squadrone Vincenzo, Richiardi Lorenzo, Marchiaro Giovana, Del Sorbo Lorenzo, Mascia Luciana, Merletti Franco, Ranieri V Marco
Dipartimento di Anestesia e Rianimazione, Azienda Ospedaliera S. Giovanni Battista-Molinette, Università di Torino, Italy.
Ann Surg. 2008 Apr;247(4):617-26. doi: 10.1097/SLA.0b013e3181675829.
We evaluated the potential benefit of continuous positive airway pressure (CPAP) to prevent postoperative pulmonary complications (PPCs), atelectasis, pneumonia, and intubation in patients undergoing major abdominal surgery.
PPCs are common during the postoperative period and may be associated with a high morbidity rate. Efficacy of CPAP to prevent PPCs occurrence is controversial.
Medical literature databases were searched for randomized controlled trials examining the use of CPAP versus standard therapy in patients undergoing abdominal surgery. The meta-analysis estimated the pooled risk ratio and the number needed to treat to benefit (NNTB) for PPCs, atelectasis, and pneumonia.
The meta-analysis was carried out over 9 randomized controlled trials. Overall, CPAP significantly reduced the risk of (1) PPCs (risk ratio, 0.66; 95% confidence interval [CI], 0.52-0.85) with a corresponding NNTB of 14.2 (95% CI, 9.9-32.4); (2) atelectasis (risk ratio, 0.75; 95% CI, 0.58-0.97; NNTB, 7.3; 95% CI, 4.4-64.5); (3) pneumonia (risk ratio, 0.33; 95% CI, 0.14-0.75; NNTB, 18.3; 95% CI, 14.4-48.8). In all cases the variation in risk ratio attributable to heterogeneity was negligible, although there was some evidence of publication bias.
This systematic review suggests that CPAP decreases the risk of PPCs, atelectasis, and pneumonia and supports its clinical use in patients undergoing abdominal surgery.
我们评估了持续气道正压通气(CPAP)对预防接受腹部大手术患者术后肺部并发症(PPCs)、肺不张、肺炎及插管的潜在益处。
PPCs在术后期间很常见,且可能与高发病率相关。CPAP预防PPCs发生的疗效存在争议。
检索医学文献数据库,查找关于在接受腹部手术患者中使用CPAP与标准治疗进行对比的随机对照试验。荟萃分析估计了PPCs、肺不张和肺炎的合并风险比及需治疗获益人数(NNTB)。
对9项随机对照试验进行了荟萃分析。总体而言,CPAP显著降低了以下风险:(1)PPCs(风险比为0.66;95%置信区间[CI]为0.52 - 0.85),相应的NNTB为14.2(95%CI为9.9 - 32.4);(2)肺不张(风险比为0.75;95%CI为0.58 - 0.97;NNTB为7.3;95%CI为4.4 - 64.5);(3)肺炎(风险比为0.33;95%CI为0.14 - 0.75;NNTB为18.3;95%CI为14.4 - 48.8)。在所有情况下,尽管有一些发表偏倚的证据,但归因于异质性的风险比变化可忽略不计。
本系统评价表明,CPAP可降低PPCs、肺不张和肺炎的风险,并支持其在接受腹部手术患者中的临床应用。